Factor IX concentrate therapy and thrombosis: Relation to changes in plasma antithrombin III
- 1 July 1986
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 43 (2), 143-151
- https://doi.org/10.1016/0049-3848(86)90055-1
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Assessment of thrombogenicity of prothrombin complex concentrates in a porcine modelThrombosis Research, 1985
- Fatal Myocardial Necrosis Associated with Prothrombin-Complex–Concentrate Therapy in Hemophilia ANew England Journal of Medicine, 1983
- Antithrombin assay - the use of human or bovine thrombin and the observation of a “second” heparin cofactorThrombosis Research, 1982
- Acute myocardial infarction in a young hemophiliac patient during therapy with Factor IX concentrate and epsilon aminocaproic acidThe Journal of Pediatrics, 1981
- PROTHROMBIN COMPLEX CONCENTRATES: CLINICAL USE*Annals of the New York Academy of Sciences, 1981
- Hazards of Prothrombin-Complex Concentrates in Treatment of HemophiliaNew England Journal of Medicine, 1981
- Multiple dental extractions with a new prothrombin complex concentrate in two patients with factor VIII inhibitorsThrombosis Research, 1979
- Therapy with Factor IX Concentrate Resulting in DIC and Thromboembolic PhenomenaTransfusion, 1978
- Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH)Thrombosis Research, 1977
- Plasma and serum antithrombin - III: Differentiation by crossed immunoelectrophoresisThrombosis Research, 1975